Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 90 | ECE2023 | Next issue

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

Card image cap
ECE 2023 will be held in Istanbul, Turkey from 13-16 May 2023. Istanbul is known for its rich culture, historical sites and dynamic nightlife, and we are excited to come together in this city, and look forward to meeting old friends, making new ones, and sharing science, collaborations and ideas.

Oral Communications

Oral Communications 11: Late Breaking

ea0090oc11.1 | Oral Communications 11: Late Breaking | ECE2023

Copper-based therapeutics increase sodium/iodide symporter (NIS) transcription and enhance radioiodide uptake in thyroid cancer cells

Brookes Katie , Zha Ling , Kim Jana , Small Benjamin , Kocbiyik Merve , Manivannan Selvambigai , Kannappan Vinodh , Wang Weiguang , Sunassee Kavitha , Blower Philip , Nieto Hannah , Smith Vicki , Read Martin , Mccabe Christopher

Introduction: New drug approaches are urgently required to improve radioiodide (RAI) uptake for efficient ablation of thyroid cancer cells in RAI-refractory disease. Employing high-throughput screening of FDA-approved compounds we recently identified drugs capable of robust induction of sodium iodide symporter (NIS) activity to promote RAI uptake1. In particular, a leading drug candidate – the well-established anti-alcoholism drug disulfiram (DSF) – had no...

ea0090oc11.2 | Oral Communications 11: Late Breaking | ECE2023

Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk

Melson Eka , Rocha Thais P. , Veen Roland J. , Abdi Lida , Mcdonnell Tara , Tandl Veronika , Hawley James M. , Wittemans Laura B.L. , Anthony Amarah V. , Gilligan Lorna C. , Shaheen Fozia , Kempegowda Punith , Gillett Caroline D.T , Cussen Leanne , Missbrenner Cornelia , Lajeunesse-Trempe Fannie , Gleeson Helena , Aled Rees D. , Robinson Lynne , Jayasena Channa , Randeva Harpal S. , Dimitriadis Georgios K. , Gomes Larissa , Sitch Alice J. , Vradi Eleni , Taylor Angela E. , O'Reilly Michael W. , Obermayer-Pietsch Barbara , Biehl Michael , Arlt Wiebke

Introduction: Polycystic ovary syndrome affects 10% of women and comes with a 2-3fold increased risk of type 2 diabetes, hypertension, and fatty liver disease. Androgen excess, a cardinal feature of PCOS, has been implicated as a major contributor to metabolic risk. Adrenal-derived 11-oxygenated androgens represent an important component of PCOS-related androgen excess and are preferentially activated in adipose tissue. We aimed to identify PCOS sub-types with distinct androge...

ea0090oc11.3 | Oral Communications 11: Late Breaking | ECE2023

Effects of semaglutide, PYY3-36, antagonists of the GLP-1/NPY-Y2 receptors, and empagliflozin on non-alcoholic fatty liver disease

Haerting Niklas , Herzog Gloria , Nickel Alexander , Kohlhaas Michael , Fassnacht Martin , Ziegler Christian , Dischinger Ulrich

Background: Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity in obese individuals. GLP-1 agonists, such as semaglutide, and SGLT-2 inhibitors, such as empagliflozin, are well known to be beneficial in NAFLD, while other incretins, like peptide tyrosine tyrosine 3-36 (PYY3-36), might be also useful for the treatment of NAFLD. We directly compared the effects of semaglutide alone and in combination with peptide tyrosine tyrosine 3-36 (PYY3-36), empagliflozin and...

ea0090oc11.4 | Oral Communications 11: Late Breaking | ECE2023

Persistence of mild hypercortisolism in patients with Cushing’s disease treated with cortisol-lowering drugs : the Haircush study

Manon Fafin , Mohammedi Kamel , Bertherat Jerome , Raverot Gerald , DRUI Delphine , Yves Reznik , Castinetti Frederic , Chanson Philippe , Corentin Rouvray , Amandine Galioot , Brossaud Julie , Tabarin Antoine

Background: Medical treatment with cortisol-lowering drugs is commonly used following pituitary surgical failure or recurrence of hypercortisolism in patients with Cushing’s disease (CD). Studies using late-night salivary cortisol (LNSF) measurement have shown persistent disruption of the circadian secretion of cortisol despite normalization of UFC in a subset of medically treated CD patients. Study aim Our objective was to assess the long-term cortisol exposure in CD pat...

ea0090oc11.5 | Oral Communications 11: Late Breaking | ECE2023

Calcium and vitamin D supplementation in rats with sulpiride-induced hyperprolactinemia

Radojkovic Danijela , Pesic Milica , Ćirić Vojislav , Radenković Saša , Radojkovic Milan

Background: Hyperprolactinemia, caused by chronic use of antipsychotics, is associated with impaired bone density and increased risk of fractures. We examined if calcium and vitamin D supplementation have influence on Prlr gene expression in the duodenum, vertebrae and kidneys in female rats with sulpiride-induced hyperprolactinemia.Methods: Wistar female rats 21 weeks old were divided into: Group S: 10 rats that were intramuscular administrated Sulpirid...

ea0090oc11.6 | Oral Communications 11: Late Breaking | ECE2023

Assessment of clinical and histopathological predictors for remission after transsphenoidal surgery for acromegaly

Postma Mark , Westerlaan Henriette , Willems Annet , van den Beukel Anke , Kuijlen Jos , Vergeer Rob , van der Klauw Melanie , Dunnen Wilfred den , van Beek Andre

Background: Transsphenoidal surgery (TSS) is the primary treatment of choice in acromegaly. Previous research succeeded to some extent in predicting remission after TSS. However, it was based mainly on clinical and radiological data, lacking histopathological evaluation.Objective: To produce a clinicopathological prediction model for remission after TSS for acromegaly, enabling clinicians to better inform patients on expected treatment outcome.<p cla...